On September 14th and 15th leaders of the CME Community including Thomas Sullivan, of Policy and Medicine will be meeting on a variety of issues related to CME at the 4th Annual Forum on Educational Grants for the Bio/Pharmaceutical Industry in Philadelphia.
Tom will be presenting two topics:
On Monday December 14th
Discuss Conflict of Interests, IOM, CEJA and New ACCME Regulations
Recent reports and criticism surround the debate on how commercial support for CME affects conflict of interest and bias. Mounting criticism has impacted accredited CME causing fundamental changes within institutions, societies, funders and healthcare organizations and the need to address conflict of interest and control bias. The CME community is seeing a shift towards greater transparency. During this session, hear updates on recent reports (IOM, CEJA, etc.) and new ACCME regulations dealing with these issues. How will they impact the way industry continues to review and analyze medical education programs for grants?
- Examine recent reports and regulations
- Discuss the impact on authors and program content
- Review how institutions have shifted their policies
- Look at how providers are adapting to these changes
With Brad Bednarz the Chief Strategy Officer at Visible Productions
On Tuesday December 15th
Healthcare Reform and Political Context of Medical Education
What impact will the stimulus package and healthcare reform have on medical education? With new congressional initiatives, MedEd focus has concentrated on issues like comparative effectiveness, strategic planning and understanding potential outcomes. Where will CME fall within congressional initiatives? Participate in an open discussion on the healthcare reform and identify the impact on medical education. During the final Q&A portion of this session, audience members identify practical solutions for funding educational programs in alignment with the healthcare reform and future congressional initiatives.
- Review the passage of the stimulus package and the healthcare reform
- Discuss how comparative effectiveness plays a role in medical education
- Analyze effective maintenance of certification CME and medical board requirements
Other Speakers include:
- Beth Brillinger, CCMEP, Senior Manager, Medical Education Grants Office (MEGO), AstraZeneca LP
- Derek T. Dietze, MA, CCMEP, President, Improve CME, LLC.
- Marc Eigner, Partner, Polaris Solutions
- Sue Garnett, RPh, MBA, Executive Director, Scientific Education, Celgene
- Patty Jassak, Senior Director, Medical Education, sanofi-aventis
- Elizabeth Jobes, JD, Chief Compliance Officer, Adolor
- Bryan King, Director, Medical Education, GlaxoSmithKline
- Sharyn S. Lee, RN, MS, DHL, CCMEP, President and CEO, MEBN
- Stephen M. Lewis, MA, CCMEP, President, Global Education Group
- Brian S. McGowan, Ph.D., CCMEP, Senior Director, Independent Medical Education, Wyeth Pharmaceuticals
- Mindi McKenna, Ph.D., MBA, Director, Division of Continuing Medical Education, American Academy of Family Physicians
- Bob Meinzer, Senior Director, National CME, NJAFP
- William Mencia, M.D., Vice President, Education & Medical Affairs, Med-IQ
- Lisa Miller, Pharm.D., MBA, Executive Director, Healthcare Education and Liaison Programs, Purdue Pharma L.P.
- Karen M. Overstreet, EdD, RPh, FACME, CCMEP, Executive Director, Lippincott CME Institute, Wolters Kluwer Health Medical Research; President, National Commission for Certification of CME Professionals
- Sam Patel, RPh, MBA, Director National Education & Strategy (NES), MEDA Pharmaceuticals
- Karen Roy, Director, Medical Education, Cephalon Inc.
- Edward Wang, Ph.D., Medical Director, Scientific Officer, sanofi-aventis
To register for the conference: https://www.cbireg.com/webreg/RegGate.wbr?PC09169